Action Merck & - 0QAH

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

84,10

Prix Achat

81,50

Prix Vente

86,70

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

83,60 Plage de 52 semaines 133,40

Cap du marché

213,111B

Clôture Veille

83,60

Ouverture

Dernière Transaction

82.4312

(O)

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

19 933

Actions en circulation

2 534 023 000

Rendement du Dividende

Ratio Cours sur Bénéfices

576,46

Bénéfice par action (BPA)

0,14

Chiffre d'affairess

60,12B

Bénéfice net

365M

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.merck.com

Siège social

West Trenton, New Jersey, USA

Fondé

Merck & Co Inc est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0QAH. Le dernier cours de clôture d'Merck & était de US$83,60. Au cours de la dernière année, les actions de Merck & ont été négociées dans une fourchette de prix de US$ 83,60 à US$ 133,40.

Merck & compte actuellement 2 534 023 000 actions en circulation. La capitalisation boursière d'Merck & est de US$211,84 milliard. Merck & a un ratio cours/bénéfice (ratio PE) de 576.46.

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-3.7	-4.21412300683	87.8	87.8	83.6	16436	85.8907811	DE
4	-15	-15.1362260343	99.1	99.55	83.6	40996	94.71005646	DE
12	-17.1	-16.8972332016	101.2	103.5	83.6	19933	96.41800953	DE
26	-29.3	-25.8377425044	113.4	119.2	83.6	15497	100.79134825	DE
52	-42.4	-33.5177865613	126.5	133.4	83.6	52874	123.16843044	DE
156	7.35	9.57654723127	76.75	133.4	73.75	100807	107.57818588	DE
260	1.3	1.57004830918	82.8	133.4	67.7	69768	103.49100443	DE

0QAH - Frequently Asked Questions (FAQ)

What is the current Merck & share price?

The current share price of Merck & is US$ 84,10

How many Merck & shares are in issue?

Merck & has 2 534 023 000 shares in issue

What is the market cap of Merck &?

The market capitalisation of Merck & is USD 211,84B

What is the 1 year trading range for Merck & share price?

Merck & has traded in the range of US$ 83,60 to US$ 133,40 during the past year

What is the PE ratio of Merck &?

The price to earnings ratio of Merck & is 576,46

What is the cash to sales ratio of Merck &?

The cash to sales ratio of Merck & is 3,5

What is the reporting currency for Merck &?

Merck & reports financial results in USD

What is the latest annual turnover for Merck &?

The latest annual turnover of Merck & is USD 60,12B

What is the latest annual profit for Merck &?

The latest annual profit of Merck & is USD 365M

What is the registered address of Merck &?

The registered address for Merck & is 820 BEAR TAVERN ROAD, WEST TRENTON, NEW JERSEY, 08628 1021

What is the Merck & website address?

The website address for Merck & is www.merck.com

Which industry sector does Merck & operate in?

Merck & operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SCGLSealand Capital Galaxy Limited	3,00p (40,19%)	20,44M
MET1Metals One Plc	0,35p (27,27%)	4,88M
CGNRConroy Gold & Natural Resources Plc	2,95p (20,41%)	3,1M
FCMFirst Class Metals Plc	2,20p (15,79%)	925,02k
TEKTekcapital Plc	10,50p (14,88%)	1,77M
SYMESupply@me Capital Plc	0,0048p (-28,89%)	5,03B
VIDVidendum Plc	66,90p (-23,98%)	1,79M
EUZEuropa Metals Ltd	1,60p (-20,00%)	35,46k
ARKArkle Resources Plc	0,20p (-20,00%)	537,63k
GFINGfinity Plc	0,10p (-16,67%)	312,27M
SYMESupply@me Capital Plc	0,0048p (-28,89%)	5,03B
BZTBezant Resources Plc	0,024p (4,35%)	502,25M
MSMNMosman Oil And Gas Limited	0,04p (2,56%)	360,68M
TRPTower Resources Plc	0,0265p (0,00%)	330,93M
GFINGfinity Plc	0,10p (-16,67%)	312,27M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Merck & Co Inc (0QAH)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Merck & Co Inc

0QAH Dernières nouvelles

Merck hits 2025 sales guidance; pauses Gardasil China shipments

IN BRIEF: Merck announces USD10 billion share buyback authorisation

IN BRIEF: Merck says HPV vaccines allegations "have no merit"

Merck agrees USD1.9 billion deal with Hansoh to develop obesity drug

IN BRIEF: Merck and AstraZeneca unveil long-term Lynparza results

*Astrazencea and Merck & Co to continue trialling lynparza across multiple cancer types

*Merck & Co says lynparza linked to "clinically meaningful prolonged survival" of patients

*Astrazeneca partnered with Merck & Co on lynparza cancer treatment trial

*Merck & Co notes positive results in phase-3 trial of Lynparza breast cancer treatment

IN BRIEF: Merck trial shows Koselugo effective in treating adults

Merck hits 2025 sales guidance; pauses Gardasil China shipments

IN BRIEF: Merck announces USD10 billion share buyback authorisation

IN BRIEF: Merck says HPV vaccines allegations "have no merit"

Merck agrees USD1.9 billion deal with Hansoh to develop obesity drug

IN BRIEF: Merck and AstraZeneca unveil long-term Lynparza results

*Astrazencea and Merck & Co to continue trialling lynparza across multiple cancer types

*Merck & Co says lynparza linked to "clinically meaningful prolonged survival" of patients

*Astrazeneca partnered with Merck & Co on lynparza cancer treatment trial

0QAH - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Merck & Co Inc (0QAH) Cours

Merck & Co Inc (0QAH)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Merck & Co Inc

0QAH Dernières nouvelles

Merck hits 2025 sales guidance; pauses Gardasil China shipments

IN BRIEF: Merck announces USD10 billion share buyback authorisation

IN BRIEF: Merck says HPV vaccines allegations "have no merit"

Merck agrees USD1.9 billion deal with Hansoh to develop obesity drug

IN BRIEF: Merck and AstraZeneca unveil long-term Lynparza results

*Astrazencea and Merck & Co to continue trialling lynparza across multiple cancer types

*Merck & Co says lynparza linked to "clinically meaningful prolonged survival" of patients

*Astrazeneca partnered with Merck & Co on lynparza cancer treatment trial

*Merck & Co notes positive results in phase-3 trial of Lynparza breast cancer treatment

IN BRIEF: Merck trial shows Koselugo effective in treating adults

Merck hits 2025 sales guidance; pauses Gardasil China shipments

IN BRIEF: Merck announces USD10 billion share buyback authorisation

IN BRIEF: Merck says HPV vaccines allegations "have no merit"

Merck agrees USD1.9 billion deal with Hansoh to develop obesity drug

IN BRIEF: Merck and AstraZeneca unveil long-term Lynparza results

*Astrazencea and Merck & Co to continue trialling lynparza across multiple cancer types

*Merck & Co says lynparza linked to "clinically meaningful prolonged survival" of patients

*Astrazeneca partnered with Merck & Co on lynparza cancer treatment trial

0QAH - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités